Dashboard
Manage Tickers

ABT


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
UPDATE: 'Abbott Weighs Takeover of Cancer ...
11/19/2025 18:41:40

https://www.bloomberg.com/news/articles/2025-11-19/abbott-weighs-takeover-of-cancer-test-maker-exact-sciences

what-does-the-market-think-about-abbott-laboratories
What Does the Market Think About Abbott La...
11/14/2025 15:00:34

is-the-market-bullish-or-bearish-on-abbott-laboratories
Is the Market Bullish or Bearish on Abbott...
10/28/2025 18:01:18

a-look-into-abbott-laboratories-incs-price-over-earnings
A Look Into Abbott Laboratories Inc's Pric...
10/22/2025 15:02:06

correction-abbott-laboratories-reported-q3-2025-results-on-oct-15-2025
CORRECTION: Abbott Laboratories Reported Q...
10/21/2025 14:39:33

Core News & Articles
Abbott Says Walmart Is First U.S. Retailer...
10/21/2025 13:01:11

- Reuters

barclays-maintains-overweight-on-abbott-laboratories-raises-price-target-to-162
Barclays Maintains Overweight on Abbott La...
10/17/2025 13:19:13

Barclays analyst Matt Miksic maintains Abbott Laboratories (NYSE:ABT) with a Overweight and raises the price target from $15...

analyst-sees-noise-in-q3-pl-affirms-abbotts-medtech-strength
Analyst Sees Noise In Q3 P&L, Affirms Abbo...
10/16/2025 17:52:03

Abbott eyes 10% EPS growth in 2026 with CGM momentum, new nutrition contracts, and medical device launches driving global expan...

these-analysts-revise-their-forecasts-on-abbott-following-q3-results
These Analysts Revise Their Forecasts On A...
10/16/2025 16:50:42

raymond-james-maintains-outperform-on-abbott-laboratories-raises-price-target-to-146
Raymond James Maintains Outperform on Abbo...
10/16/2025 16:07:48

Raymond James analyst Jayson Bedford maintains Abbott Laboratories (NYSE:ABT) with a Outperform and raises the price target ...

evercore-isi-group-maintains-outperform-on-abbott-laboratories-lowers-price-target-to-142
Evercore ISI Group Maintains Outperform on...
10/16/2025 14:48:29

Evercore ISI Group analyst Vijay Kumar maintains Abbott Laboratories (NYSE:ABT) with a Outperform and lowers the price targe...

rbc-capital-reiterates-outperform-on-abbott-laboratories-maintains-147-price-target
RBC Capital Reiterates Outperform on Abbot...
10/16/2025 13:59:19

RBC Capital analyst Shagun Singh reiterates Abbott Laboratories (NYSE:ABT) with a Outperform and maintains $147 price target.

wells-fargo-maintains-overweight-on-abbott-laboratories-raises-price-target-to-146
Wells Fargo Maintains Overweight on Abbott...
10/16/2025 13:45:07

Wells Fargo analyst Lawrence Biegelsen maintains Abbott Laboratories (NYSE:ABT) with a Overweight and raises the price targe...

gold-gains-over-1-abbott-shares-fall-after-q3-results
Gold Gains Over 1%; Abbott Shares Fall Aft...
10/15/2025 18:20:16

bank-earnings-lift-wall-street-gold-hits-4200-whats-moving-markets-wednesday
Bank Earnings Lift Wall Street, Gold Hits ...
10/15/2025 17:06:54

Wall Street rose on Wednesday, with investor optimism lifted by strong bank and corporate earnings alongside growing expectatio...

abbott-tightens-annual-sales-forecast-as-q3-sales-miss-expectations
Abbott Tightens Annual Sales Forecast As Q...
10/15/2025 13:16:02

Abbott stock fell as Q3 sales missed estimates and 2025 earnings guidance was narrowed despite solid growth in medical devices.

stock-market-today-sp-500-nasdaq-futures-rise-bank-of-america-morgan-stanley-abbott-earnings-in-focus-updated
Stock Market Today: S&P 500, Nasdaq Future...
10/15/2025 13:05:49

Editor’s note: The future prices of benchmark tracking ETFs, the lede, and the latest economic releases were updated in the sto...

abbott-laboratories-narrows-fy2025-adj-eps-guidance-from-510-520-to-512-518-vs-515-est
Abbott Laboratories Narrows FY2025 Adj EPS...
10/15/2025 11:33:58

ABBOTT'S FINANCIAL GUIDANCEAbbott reaffirms previously provided full-year 2025 organic sales growth guidance of 7.5% to 8.0...

abbott-laboratories-q3-2025-adj-eps-130-inline-sales-11369b-miss-11404b-estimate
Abbott Laboratories Q3 2025 Adj. EPS $1.30...
10/15/2025 11:32:14

Core News & Articles
Earnings Scheduled For October 15, 2025
10/15/2025 08:32:12

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION